San Francisco, United States
Codon Capital is a San Francisco-based biotech venture capital company, specializing in therapeutics and synthetic biology. Our series A investment approach is to fund startup teams that can execute on difficult technical, definable achievements that enable breakthrough biotech products. We’re investing in solutions to the most critical problems of human health and sustainability, and in teams who can make the impossible possible.
8
Total Investments
7
Portfolio Companies
-
Exits
1
Industries
General Information
Industries
Biotechnology
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Codon Capital
Recent Investments (8)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | Jan 2026 | |
| Series B | •••••• | Dec 2023 | |
| Early VC | •••••• | Sep 2023 | |
| Series A | •••••• | Jul 2023 | |
| Series A | •••••• | Nov 2022 | |
•••• ••••
|
Series A | •••••• | Apr 2022 |
|
•••• ••••
|
Series A | •••••• | May 2020 |
|
•••• ••••
|
Series C | •••••• | Apr 2020 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
